on 12 Feb 2019
Last Applicant/ Owned by
4130 Parklake Avenue, Suite 400
Raleigh
NC
27612
Serial Number
86633276 filed on 18th May 2015
Registration Number
5675534 registered on 12th Feb 2019
Correspondent Address
Robin C. Vance
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical research services, namely, clinical research and development; medical and scientific research, namely, conducting clinical trials, medical research, research in the field of biotechnology pharmaceutical research services, medical monitoring, pharmacovigilance in the nature of detection, assessment, and prevention of adverse effects of drugs and other drug-related problems, statistic Read More
Regulatory affairs consulting services, namely, regulatory compliance consulting in the field of pharmaceutical development
30th Jun 2015
30th Jun 2015
Pharmaceutical research services, namely, clinical research and development; medical and scientific research, namely, conducting clinical trials, medical research, research in the field of biotechnology pharmaceutical research services, medical monitoring, pharmacovigilance in the nature of detection, assessment, and prevention of adverse effects of drugs and other drug-related problems, statistical analysis, medical writing, and drug logistics, all in the field of clinical research; maintenance of databases for others; providing the services of data management, namely, data compiling, analyzing and tracking in the field of clinical trials for research purposes
30th Jun 2015
30th Jun 2015
Data management, namely, data processing services in the nature of the collection, organization, management, analysis and reporting of data gathered in connection with the conduct of a clinical research trial; biostatistics consulting, namely, consulting related to the collection, summarization, and analysis of statistical information from clinical research trials and the interpretation of, and inference from, the results of such trials for use in the biomedical and pharmaceutical industries for business or commercial purposes; providing technical consulting services and information management services, namely, clinical data and regulatory submission management to medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; providing the services of project management, namely, business project management in the field of clinical trials; providing the services of site management, namely, identifying, qualifying, and selecting sites for clinical trials, negotiating clinical trial site contracts and budgets, organizing and conducting business meetings of clinical trial investigators, assisting investigators with developing business strategies for recruiting clinical trial participants, submitting clinical trial protocols to institutional review boards and independent ethics committees, and business management services in the nature of monitoring clinical trial investigators' activities for compliance with clinical protocols and regulations and for patient safety; providing the services of data management, namely, data compiling, analyzing and tracking in the field of clinical trials for business purposes; providing the services of vendor management to medical, pharmaceutical, biopharmaceutical and biotechnology companies, namely, selecting and managing third-party providers of services that support clinical trials
30th Jun 2015
30th Jun 2015
No 86633276
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
12th Feb 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
14th Jul 2021 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
12th Feb 2019 | REGISTERED-PRINCIPAL REGISTER |
09th Jan 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
08th Jan 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
17th Dec 2018 | STATEMENT OF USE PROCESSING COMPLETE |
13th Dec 2018 | TEAS STATEMENT OF USE RECEIVED |
13th Dec 2018 | USE AMENDMENT FILED |
11th Jul 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
10th Jul 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |